1. The role of polygenic risk scores in breast cancer risk perception and decision-making;J Community Genet,2023
2. "It's personalized, but it's still bucket based": The promise of personalized medicine vs. the reality of genomic risk stratification in a breast cancer screening trial;New Genet Soc,2022
3. The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial;PLoS One,2021
4. A qualitative study of unaffected ATM and CHEK2 carriers: How participants make meaning of 'moderate risk' genetic results in a population breast cancer screening trial;J Genet Couns,2022
5. NCI Budget Fact Book—Research Funding—NCI (nciglobal,ncienterprise);National Cancer Institute,2022